Clinical Trials
13 trialsNCT06241352 2025-05-11
Statin Addition to Chemotherapy for Advanced Pancreatic Cancer
Changhai Hospital
Phase 2 Completed
NCT03336216 2024-07-23
A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
Bristol-Myers Squibb
Phase 2 Completed
NCT06422156 2024-05-20
Nim-PC-28
Peking University Third Hospital
Phase 2 Not yet recruiting
NCT06329947 2024-05-08
A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06111274 2024-04-11
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
Abbisko Therapeutics Co, Ltd
Phase 2 Recruiting
NCT04617067 2024-03-06
Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer
Cancer Trials Ireland
Phase 2 Completed
NCT05298020 2022-03-28
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT01303172 2021-11-10
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Immodulon Therapeutics Ltd
Phase 2 Completed
NCT05100329 2021-10-29
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
NCT03415802 2021-02-01
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Completed
NCT03662035 2018-09-19
ASPC
Changzhou No.2 People's Hospital
Phase 2 Unknown
NCT02124317 2016-12-22
NAPSPAC
Chinese PLA General Hospital
Phase 2 Unknown
NCT02135822 2014-05-16
NAPGAP
Chinese PLA General Hospital
Phase 2 Unknown